Opening book details…
About this Medicine article
Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study by Kimura, Kiminori (author);Kanto, Tatsuya (author);Shimoda, Shinji (author);Harada, Kenichi (author);Kimura, Masamichi (author);Nishikawa, Koji (author);Imamura, Jun (author);Ogawa, Eiichi (author);Saio, Masanao (author);Ikura, Yoshihiro (author);Okusaka, Takuji (author);Inoue, Kazuaki (author);Ishikawa, Tetsuya (author);Ieiri, Ichiro (author);Kishimoto, Junji (author);Todaka, Koji (author);Kamisawa, Terumi (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Kimura, Kiminori (author);Kanto, Tatsuya (author);Shimoda, Shinji (author);Harada, Kenichi (author);Kimura, Masamichi (author);Nishikawa, Koji (author);Imamura, Jun (author);Ogawa, Eiichi (author);Saio, Masanao (author);Ikura, Yoshihiro (author);Okusaka, Takuji (author);Inoue, Kazuaki (author);Ishikawa, Tetsuya (author);Ieiri, Ichiro (author);Kishimoto, Junji (author);Todaka, Koji (author);Kamisawa, Terumi (author)
- Publisher
- Elsevier BV
- Published
- 2022
- Field
- Medicine (Life Sciences)